From: Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
Sex | Â | Male | Female |
---|---|---|---|
Sample number | Â | 156 | 119 |
s-PCK1-Ab level | Average | 4,823 | 4,692 |
SD | 4,588 | 2,940 | |
P value (vs Male) | Â | Â | 0.5812 |
DM type | Â | Type-1 DM | Type-2 DM |
Sample number | Â | 28 | 215 |
s-PCK1-Ab level | Average | 3,866 | 5,058 |
SD | 2,462 | 4,271 | |
P value (vs BMI < 25) |  |  | 0.0642 |
Obesity |  | BMI < 25 | BMI ≥ 25 |
Sample number | Â | 156 | 114 |
s-PCK1-Ab level | Average | 5,066 | 4,379 |
SD | 4,660 | 2,782 | |
P value (vs BMI < 25) |  |  | 0.3676 |
Complication |  | Hypertension- | Hypertension +  |
Sample number | Â | 144 | 240 |
s-PCK1-Ab level | Average | 6,105 | 7,666 |
SD | 4,927 | 6,750 | |
P value (vs HT-) | Â | Â | 0.0198* |
Complication |  | CVD- | CVD +  |
Sample number | Â | 257 | 18 |
s-PCK1-Ab level | Average | 4,791 | 4,415 |
SD | 4,049 | 2,230 | |
P value (vs CVD-) | Â | Â | 0.7568 |
Complication |  | Dyslipidemia- | Dyslipidemia +  |
Sample number | Â | 237 | 26 |
s-PCK1-Ab level | Average | 4,955 | 3,767 |
SD | 4,154 | 2,081 | |
P value (vs Dyslipidemia-) | Â | Â | 0.0941 |
Life style | Â | Non-smoker | Smoker |
Sample number | Â | 142 | 131 |
s-PCK1-Ab level | Average | 4,491 | 5,015 |
SD | 2,863 | 4,834 | |
P value (vs Non-smoker) | Â | Â | 0.5445 |
Life style |  | Alcohol- | Alcohol +  |
Sample number | Â | 160 | 114 |
s-PCK1-Ab level | Average | 4,560 | 5,071 |
SD | 2,842 | 5,134 | |
P value (vs Alcohol-) | Â | Â | 0.9975 |
Medication |  | Antihypertensive- | Antihypertensive +  |
Sample number | Â | 106 | 159 |
s-PCK1-Ab level | Average | 4,850 | 4,660 |
SD | 4,982 | 3,169 | |
P value (vs Alcohol-) | Â | Â | 0.8093 |